RxDoctor Payments Data

Meredith Hamilton, APRN

Nurse Practitioner · Signal Mountain, TNNPI 1528763588

Payments from drug & device makers

$1,063in general payments, 2019–2025

Across 50 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$207
  • AstraZeneca$181
  • Pharmacosmos Therapeutics Inc.$101
  • AbbVie$89
  • Idorsia Pharmaceuticals US Inc$75
  • Dexcom, Inc.$73
  • plus $337 from 9 others

What the payments were for

  • Food & beverage$1,063100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,063 in reported general payments places this provider in the 70th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$77,945
Medicare patients
222
Services billed
1,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban66$33,136
FarxigaDapagliflozin Propanediol19$22,972
OzempicSemaglutide11$18,994
Lidocaine25$2,914
Losartan Potassium113$1,312
Rosuvastatin Calcium65$1,282
Atorvastatin Calcium111$1,237
Pregabalin14$1,154
Albuterol Sulfate HfaAlbuterol Sulfate36$1,058
Omeprazole87$948
Levothyroxine Sodium103$921
Gabapentin50$894
Memantine Hcl28$736
Amlodipine Besylate84$668
Donepezil Hcl69$666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$60$33,13666 claims
AstraZenecaFarxiga$181$22,97219 claims
Novo NordiskOzempic$207$18,99411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Signal Mountain

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →